Patents by Inventor Colin STUBBERFIELD

Colin STUBBERFIELD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210238139
    Abstract: There are described compounds of formula (I): (I) and their use as a medicament in the treatment of diseases associated with the abnormal or elevated catabolism of tryptophan, such as, cancer, immunosuppression, viral infection, depression, a neurodegenerative disorder, trauma, age-related cataracts, organ transplant rejection, or an autoimmune disorder in a patient.
    Type: Application
    Filed: May 31, 2019
    Publication date: August 5, 2021
    Applicant: E-Therapeutics PLC
    Inventors: Tanja Poljak, Marina Modric, Srinivasamurthy Vadlamudi, Colin Stubberfield
  • Patent number: 10961238
    Abstract: There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD).
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: March 30, 2021
    Assignee: E-THERAPEUTICS PLC
    Inventors: Maja Ro{hacek over (s)}cic, Filip Kolund{hacek over (z)}ic, Dinko {hacek over (Z)}iher, Tanja Poljak, Srinivasamurthy Vadlamudi, Colin Stubberfield
  • Publication number: 20200055847
    Abstract: There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD).
    Type: Application
    Filed: October 25, 2017
    Publication date: February 20, 2020
    Applicant: e-Therapeutics PLC
    Inventors: Maja ROSCIC, Filip KOLUNDZIC, Dinko ZIHER, Tanja POLJAK, Srinivasamurthy VADLAMUDI, Colin STUBBERFIELD